Nevertheless, our cohort is the largest to date in which the clinicpathological characteristics and recurrence patterns regarding mutations in PI3K/AKT pathway genes and PIK3CA amplifications in gastric cancers were investigated. This evidence concerns the gene PIK3CA and gastric cancer.